Benjamin F. Edwards & Company’s Global X Genomics & Biotechnology ETF GNOM Stock Holding History

Benjamin F. Edwards & Company’s Portfolio GNOM Stock Details GNOM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	$10K	Hold	229	–	–	﹤0.01%	1720
2024 Q1	$10K	Hold	229	–	–	﹤0.01%	1704
2023 Q4	$11K	Hold	229	–	–	﹤0.01%	1629
2023 Q3	$9K	Hold	229	–	–	﹤0.01%	1417
2023 Q2	$11K	Hold	229	–	–	﹤0.01%	1395
2023 Q1	$11K	Hold	229	–	–	﹤0.01%	1388
2022 Q4	$12K	Hold	229	–	–	﹤0.01%	1386
2022 Q3	$12K	Hold	229	–	–	﹤0.01%	1354
2022 Q2	$11K	Hold	229	–	–	﹤0.01%	1357
2022 Q1	$14K	Hold	229	–	–	﹤0.01%	1297
2021 Q4	$18K	Hold	229	–	–	﹤0.01%	1260
2021 Q3	$20K	Hold	229	–	–	﹤0.01%	1231
2021 Q2	$23K	Hold	229	–	–	﹤0.01%	1194
2021 Q1	$21K	Hold	229	–	–	﹤0.01%	1193
2020 Q4	$22K	Hold	229	–	–	﹤0.01%	1134
2020 Q3	$16K	Hold	229	–	–	﹤0.01%	1165
2020 Q2	$16K	Buy	229 +38	+20%	+$2.37K	﹤0.01%	1173
2020 Q1	$10K	Hold	191	–	–	﹤0.01%	1248
2019 Q4	$12K	Buy	191 +28	+17%	+$1.6K	﹤0.01%	1375
2019 Q3	$8K	Hold	163	–	–	﹤0.01%	1468
2019 Q2	$10K	Buy	+163	New	+$9.28K	﹤0.01%	1413

Other funds holding GNOM

OCM

One Capital Management Westlake Village, California $3.65B AUM 15.32% 1-Year Est. Return

RJFSA

Raymond James Financial Services Advisors St. Petersburg, Florida $75.1B AUM 31.89% 1-Year Est. Return

PGA

Portland Global Advisors Portland, Maine $938M AUM 13.22% 1-Year Est. Return

Mirae Asset Global ETFs Holdings Causeway Bay, Hong Kong $73.7B AUM 53.56% 1-Year Est. Return

Lido Advisors Los Angeles, California $32.7B AUM 19.2% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SWP

Stratos Wealth Partners Beachwood, Ohio $8.8B AUM 21.82% 1-Year Est. Return

OAM

Oppenheimer Asset Management New York $8.76B AUM 23.12% 1-Year Est. Return

Benjamin F. Edwards & Company's GNOM Position: Q2 2024 in Review

Benjamin F. Edwards & Company held its Global X Genomics & Biotechnology ETF (GNOM) position steady in Q2 2024 at 229 shares worth $10K. The position accounts for ﹤0.01% of the portfolio, ranked #1720.

Benjamin F. Edwards & Company first reported a position in GNOM in Q2 2019 and has held it in 21 quarters since. The position peaked at $23K in Q2 2021. 65 funds tracked by Wall St. Rank hold GNOM as of Q2 2024.

Benjamin F. Edwards & Company held 229 shares of Global X Genomics & Biotechnology ETF worth $10K as of Q2 2024.
Benjamin F. Edwards & Company left its Global X Genomics & Biotechnology ETF share count unchanged in Q2 2024.
Global X Genomics & Biotechnology ETF made up ﹤0.01% of Benjamin F. Edwards & Company's portfolio in Q2 2024, its #1720 holding.
Benjamin F. Edwards & Company first reported a position in Global X Genomics & Biotechnology ETF in Q2 2019 and has held it in 21 quarters since.
Benjamin F. Edwards & Company's Global X Genomics & Biotechnology ETF position peaked at $23K in Q2 2021.
65 funds tracked by Wall St. Rank held Global X Genomics & Biotechnology ETF as of Q2 2024.

Based on Benjamin F. Edwards & Company's 13F filing for Q2 2024, filed 12 Aug 2024.